Clinical Trials Update: June 28, 2005
Autism Lymphocytic Leukemia, Chronic Huntington's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Researchers at the Kluge Children's Rehabilitation Center are seeking children up to age 17 with autism. The aim of this research study is to establish a relationship between the severity of autism and the Apolipoprotein (Apo E) genotype. There will be no cost to you or your child for participating in this study. All participants will be enrolled during a regular clinic visit at KCRC, and examined by an educator or nurse for the purpose of rating your child's autism. Research site located in Charlottesville, Va.
Lymphocytic Leukemia, Chronic
This study will assess the efficacy and safety of adding MabThera to a standard chemotherapy regimen in patients with previously untreated B-cell chronic lymphocytic leukemia (B-CLL). Participants must be adult patients at least 18 years of age, have confirmed B-CLL, and have no previous chemotherapy, radiotherapy, or immunotherapy for the treatment of CLL. Any women of childbearing potential must have a negative serum pregnancy test seven days prior to treatment, and must be prepared to use reliable contraception during the study and for 2 months after the end of treatment. Research sites located throughout Germany, Australia, France, Denmark, Czech Republic and Israel.
This study will evaluate the effects of an experimental drug compared to placebo on symptoms of Huntington's disease over a 6-month period of observation. You may be eligible to participate if you are at least 35, have been diagnosed with Huntington's disease and a family history of Huntington's. Research site located in Manhasset, NY.
Copyright 2005 CenterWatch. All rights reserved.